Tetsuyuki Maruyama
Voorzitter bij Protekt Therapeutics Ltd.
Oorsprong van het eerstegraads netwerk van Tetsuyuki Maruyama
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona.
15
| Holding Company | Investment Managers | 15 |
Protekt Therapeutics Ltd.
 Protekt Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Protekt Therapeutics Ltd. operates as a biopharmaceutical company. The firm develop a drug for enhancing the long-term memory of those suffering from mild cognitive impairment. The company is headquartered in Ness Ziona, Israel.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Tetsuyuki Maruyama via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Masters Business Admin Graduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey. | Investment Managers | Private Equity Investor Private Equity Investor | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | President Corporate Officer/Principal | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Weizmann Institute of Science | College/University | Graduate Degree Doctorate Degree | |
MiroBio Ltd.
 MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
| Compugen Usa, Inc. | President | ||
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
A2i Therapeutics Ltd.
 A2i Therapeutics Ltd. Investment ManagersFinance A2i Therapeutics Ltd. is an Israeli AI-based drug-design company that aims to develop novel therapeutic modulators of the protein ADAR1, a key element of the innate immune system. The company is a joint venture of the FutuRx Incubator and Atomwise, utilizing the AtomNet® AI platform and FutuRx’s technology to translate extraordinary technologies to life-changing therapies. | Investment Managers | Director/Board Member | |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services ADARx Pharmaceuticals, Inc. operates as RNA base-editing company. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Private Equity Investor | |
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
| Metacure Israel Ltd. | Sales & Marketing | ||
OrbiMed Israel Partners LP
 OrbiMed Israel Partners LP Investment ManagersFinance OrbiMed Israel Partners LP seeks investment opportunities in life science companies located in Israel. The fund targets companies operating in the fields of biotechnology, pharmaceutical, medical device and diagnostics. It provides financing for seed, early, later and growth stage capital requirements. | Investment Managers | Corporate Officer/Principal | |
| ADICET BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MindUP Ltd. | Founder | ||
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA. | Biotechnology | Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
| BIOMX INC. | Biotechnology | Director/Board Member | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
Nucleix Ltd.
 Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Medical/Nursing Services | Director/Board Member | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Private Equity Analyst | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman | |
| Pg Medical Systems Ltd. | Director/Board Member | ||
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Edinburgh Business School | College/University | Masters Business Admin | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal | |
| Peres Academic Center | College/University | Masters Business Admin | |
| Teva Pharmaceuticals Ltd. (Israel) | Corporate Officer/Principal | ||
| NEXTGEN BIOMED LTD | Pharmaceuticals: Major | Chief Executive Officer | |
| Bloomsbury Pharma Ai Ltd | Founder | ||
Rafa Laboratories Ltd.
 Rafa Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Rafa Laboratories Ltd. engages in developing and producing cattle disease vaccines, vaccines for human use and manufactures pharmaceutical products. The company was founded by Baruch Samuel Levin in 1937 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Private Equity Investor | |
| SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
| Dartmouth College | College/University | Undergraduate Degree | |
| Columbia Business School | College/University | Masters Business Admin | |
| Columbia Law School | College/University | Graduate Degree | |
Artisan Healthcare Consulting, Inc.
 Artisan Healthcare Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Part of CMC Consulting Boston, Inc., Artisan Healthcare Consulting, Inc. is a management consulting firm that provides strategic insights to healthcare product companies. The company is based in Waltham, MA. Artisan Healthcare Consulting provides strategic and analytic advice to a wide range of healthcare product companies. The company works across the biopharma industry to help clients steer emerging therapies through clinical development, launch them successfully, and drive success throughout the life cycle of their products. The company was founded in 2009 by Bob Delise, who has been the CEO since then. Artisan Healthcare Consulting was acquired by CMC Consulting Boston, Inc. on September 06, 2022. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Corporate Officer/Principal | |
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Miscellaneous | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 26 |
| Israël | 21 |
| Verenigd Koninkrijk | 3 |
| China | 2 |
| Denemarken | 2 |
Sectoraal
| Health Technology | 25 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 5 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 72 |
| Corporate Officer/Principal | 27 |
| Independent Dir/Board Member | 11 |
| Undergraduate Degree | 11 |
| Chief Executive Officer | 10 |
Sterkste connecties
| Insiders | |
|---|---|
| Erez Chimovits | 30 |
| Zeev Zehavi | 18 |
| Marie Lindner | 18 |
| Bernhard Kirschbaum | 15 |
| Michael Gilman | 14 |
| Lee Cooper | 13 |
| Lior Teitelbaum | 11 |
| Liana Patt | 11 |
| Modi Teicher | 6 |
| Hee-Won Yoo | 5 |
| Keren Kocshitzki | 3 |
| Aric Orbach | 3 |
| Dror Haratz | 3 |
| Harry Raftopoulos | 1 |
| Steve Hitchcock | 1 |
- Beurs
- Insiders
- Tetsuyuki Maruyama
- Bedrijfsconnecties
